GHK-Cu is discussed as a potential hair loss treatment, with claims of promotinghairgrowth and possibly reversing gray hair, though strong clinical evidence is limited. The user also mentions using Minoxidil, red light therapy, and microneedling.
PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.
Clascoterone 5% solution shows strong potential for hairgrowth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.
Clascoterone 5% shows promising hairgrowth results but is criticized for high cost and unclear effectiveness compared to other treatments like finasteride. Glenmark is testing a combination of Clascoterone 7.5% and Minoxidil 5% in India.
KOSHINE826 is a new anti-hair loss and hairgrowthsolution that claims to effectively control oil, reduce hair fall, and promote real hairgrowth. It targets androgenetic alopecia by inhibiting DHT and has shown promising results in clinical trials.